HOME >> MEDICINE >> NEWS
New drug to treat enlarged prostate developed at UCL

Millions of men stand to benefit from a discovery by UCL scientists that could provide a breakthrough in the treatment of enlargement of the prostate (BPH). The UCL team has developed a new drug, Rho-kinase inhibitor that, in preliminary tests, has been found to treat the condition by both relaxing the prostate and stopping the growth of cells within it. Their findings are set out in the current issue of the Journal of Urology.

BPH affects approximately 85% of men over the age of 50 and causes frequent urination and irritation due to the obstruction of urine flow. The drugs currently available for treatment of BPH aim to either relax the prostrate or to reduce its size as two separate actions, and also have undesired hormonal effects. These effects, along with the need to take two separate treatments, often lead to problems of patient compliance. The discovery by the UCL scientists is novel in that this new drug can both relax the prostate and stop it from growing, with virtually no hormonal side effects.

Dr Selim Cellek, who led the investigation as a collaborative work between UCL's Wolfson Institute for Biomedical Research and its Institute of Urology and Nephrology, said: "We are very excited by this discovery, as it is a medical breakthrough which represents a major advance in treating a condition that affects such a large proportion of the population. We are still at the development stages and more research will be required before the new treatment becomes available. The next step will be to develop links with investors interested in developing this drug for the treatment of BPH.

"Research has shown that this type of compound can also be used to treat erectile dysfunction (impotence). The future for this line of research is therefore promising since men with an enlarged prostate often suffer from impotence. "

Malcolm Grant, UCL Provost, said: "The conversion of scientific results into new medicines is one of the main aims of th
'"/>

Contact: Dominique Fourniol
d.fourniol@ucl.ac.uk
44-207-679-9728
University College London
27-Nov-2003


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Chronic pain treatments more effective when taken together, new study shows
4. Brain activity prior to treatment flags vulnerability to antidepressant side effects
5. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
6. OHSU scientists test medication to treat involuntary weight loss
7. Cultural and social factors influence prostate cancer treatment
8. Research offers hope of new treatments for liver damage
9. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
10. Risky surgery not always necessary to treat cervical disease
11. Stanford patient is first to test new treatment for peripheral arterial disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug treat enlarged prostate developed UCL

(Date:5/26/2015)... 26, 2015 The American College of Traditional ... for the Open House/Free Application Day on Wednesday, July 22. ... 4 p.m. and will be held at ACTCM Pioneer Square, ... After checking in, attendees will be greeted with an introduction ... of the campus at 11:45 a.m. Lunch will be served ...
(Date:5/26/2015)... 2015 Irwin Gross, M.D., Accumen, ... hospital-wide Patient Blood Management (PBM) initiative at Eastern Maine ... usage by more than 60 percent and improved patient ... detail in an article in the May 2015 edition ... perioperative red cell loss, less acute kidney injury and ...
(Date:5/26/2015)... May 26, 2015 On May 26, 2015, ... 6 salesman and distributor Dwayne Windfall. At the start of ... company that has some unique characteristics with it, so could ... business?” Windfall replies saying, “I was reading the newspaper looking ... said they were looking for a person with hustle. I ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... Based on numerous suggestions put forward ... comprehensive upgrade of its purchasing page and processing, resulting ... users for their feedback and support of the website, ... transcription service promotion. , This promotion will become ... 9 this year. During this period, AnyTranscription users will ...
Breaking Medicine News(10 mins):Health News:ACTCM to Host Summer Open House 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3
(Date:5/26/2015)... SALT LAKE CITY , May 26, ... healthcare data warehousing and analytics, today launched ... educational offering designed to help health systems ... their clinical quality and operational efficiency. ... latest offering in Health Catalyst,s comprehensive suite ...
(Date:5/26/2015)... May 26, 2015 ... announced the addition of the "North ... Type (Integrated Computerized Physician Order Entry, Standalone ... Software, Services) - Forecast to 2019 " ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , The ...
(Date:5/26/2015)... ® Technologies, Inc., the leader in non-invasive, accelerated orthodontic ... to continued demand from orthodontists and patients for safe, ... locations in the U.S. and Canada ... the only FDA-cleared Class II medical device that has ... much as 50 percent.  A recent ...
Breaking Medicine Technology:Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 2Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 3Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 4North American Computerized Physician Order Entry Market 2015-2019 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3
Cached News: